Author, year N Therapy Regimen Follow-up Period
Lenz 2004[10] 240 E: CHOP×(4-6)cyc, Dex + BEAM, TBI, CY 4.2 years
C: CHOP×(4-6)cyc , CHOP×2cyc + IFNα
Sebban 2006 [11] 401 E: CHOP×4cyc, CY, VP16, TBI 7.7 years
C: CHTP×12cyc+ IFNα
Ladetto 2008[9] 134 E: (APO±DHAP)×2cyc, R×2cyc, CY±R×2cyc 4.3 years
C: CHOP×6cyc + R×(4-6)cyc
Gyan 2009 [12] 166 E: VCAP×3cyc, DHAP×3cyc or IMVP16, TBI, CY 9 years
C: CHVP×12cyc+ IFNα-2b
Abbreviations: CHOP: cyclophosphamide, doxorubicin, vincristine, prednisone; cyc: cycles, Dex: dexamethasone; BEAM: BCNU, melphalan, etoposide, cytarabine; TBI: total body irradiatioin; CY: cyclophosphamide; CHTP: cyclophosphamide,doxorubicin, teniposide, prednisone; APO: doxorubicin, vincristine, prednisone; DHAP: dexamethasone, high dose of cytarabine, and cisplatin. R: rituximab; VCAP: vindesine, cyclophosphamide, doxorubicin, prednisone; IMVP16: ifosfamide, methotrexate, and VP-16; CHVP: cyclophosphamide, doxorubicin, vepeside, prednisone.
Table 1: Characteristics of included studies.